Skip to main content

Table 2 Antibiotics susceptibilities grouped by study year

From: Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus

Antibioticsa Overall susceptibilities (%) (n = 968) Susceptibilities by years (%)
2002 (n = 495) 2012 (n = 473) P
Clindamycin 174 (18.0) 49 (9.9) 125 (26.4) < 0.001
Ciprofloxacin 432 (44.6) 224 (45.3) 208 (44.0) 0.699
Erythromycin 79 (8.2) 17 (3.4) 62 (13.1) < 0.001
Linezolid 968 (100) 495 (100) 473 (100)
Rifampicin 841 (86.9) 456 (92.1) 385 (81.4) < 0.001
SXT 557 (57.5) 236 (47.7) 321 (67.9) < 0.001
Tetracycline 281 (29.0) 70 (14.1) 211 (44.6) < 0.001
Fosfomycin 900 (93.0) 478 (96.6) 422 (89.2) < 0.001
Vancomycin 968 (100) 495 (100) 473 (100)
  1. a Antibiotic abbreviation: SXT, trimethoprim/sulfamethoxazole